Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cfMSCs for the Treatment of COPD
NCT07477600Phase 2Not yet recruiting
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Start
- Jun 2027
- Primary completion
- Jun 2029
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of clonal fetal mesenchymal stem cells in chronic obstructive pulmonary disease (COPD), sponsored by Shenzhen Geno-Immune Medical Institute. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
clonal fetal mesenchymal stem cells
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07477600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07477600.